Cwm LLC Boosts Stock Holdings in Agilent Technologies, Inc. $A

Cwm LLC grew its position in Agilent Technologies, Inc. (NYSE:A) by 21.2% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 70,390 shares of the medical research company’s stock after buying an additional 12,294 shares during the quarter. Cwm LLC’s holdings in Agilent Technologies were worth $9,035,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. BSW Wealth Partners raised its stake in Agilent Technologies by 5.3% in the 3rd quarter. BSW Wealth Partners now owns 5,597 shares of the medical research company’s stock valued at $718,000 after purchasing an additional 281 shares during the last quarter. Harbor Capital Advisors Inc. raised its position in shares of Agilent Technologies by 2.6% in the third quarter. Harbor Capital Advisors Inc. now owns 4,897 shares of the medical research company’s stock valued at $629,000 after buying an additional 125 shares during the last quarter. Swedbank AB lifted its stake in shares of Agilent Technologies by 2.1% in the third quarter. Swedbank AB now owns 164,020 shares of the medical research company’s stock worth $21,052,000 after buying an additional 3,404 shares in the last quarter. DAVENPORT & Co LLC lifted its stake in shares of Agilent Technologies by 2,466.0% in the third quarter. DAVENPORT & Co LLC now owns 253,234 shares of the medical research company’s stock worth $32,503,000 after buying an additional 243,365 shares in the last quarter. Finally, Argent Capital Management LLC boosted its position in Agilent Technologies by 3.6% during the third quarter. Argent Capital Management LLC now owns 34,116 shares of the medical research company’s stock worth $4,379,000 after acquiring an additional 1,185 shares during the last quarter.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 12,490 shares of the business’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total value of $1,873,500.00. Following the sale, the chief executive officer owned 33,448 shares of the company’s stock, valued at $5,017,200. The trade was a 27.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Rodney Gonsalves sold 3,000 shares of the firm’s stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the transaction, the vice president owned 31,846 shares of the company’s stock, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 16,401 shares of company stock worth $2,468,962.

Analysts Set New Price Targets

A has been the topic of a number of research reports. Bank of America raised their target price on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 25th. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Friday, October 3rd. TD Cowen boosted their price objective on Agilent Technologies from $150.00 to $162.00 and gave the stock a “buy” rating in a research note on Tuesday, October 14th. The Goldman Sachs Group began coverage on Agilent Technologies in a research note on Tuesday, December 9th. They issued a “buy” rating and a $170.00 target price for the company. Finally, Wells Fargo & Company lifted their price target on Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $161.77.

Agilent Technologies Price Performance

NYSE:A opened at $137.86 on Tuesday. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $160.27. The stock’s fifty day moving average is $145.20 and its two-hundred day moving average is $131.04. The company has a market capitalization of $39.08 billion, a P/E ratio of 30.17, a P/E/G ratio of 4.02 and a beta of 1.27. The company has a quick ratio of 1.52, a current ratio of 1.96 and a debt-to-equity ratio of 0.45.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. The business had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.83 billion. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The company’s revenue was up 9.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.46 EPS. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Equities analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be paid a $0.255 dividend. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Tuesday, January 6th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s payout ratio is presently 21.66%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.